[1]
Luthvia, L., Harahap, U. and Nasution, S. 2018. THE EFFECT OF ERYTHROPOIETIN DOSE PHASE OF CORRECTION AS DRUG-RELATED PROBLEMS TO TARGET LEVEL OF HEMOGLOBIN IN REGULAR HEMODIALYSIS PATIENTS. Asian Journal of Pharmaceutical and Clinical Research. 11, 5 (May 2018), 151–154. DOI:https://doi.org/10.22159/ajpcr.2018.v11i5.24313.